Ameritas Advisory Services LLC Takes Position in Xylem Inc. $XYL

Ameritas Advisory Services LLC acquired a new stake in Xylem Inc. (NYSE:XYL) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 445 shares of the industrial products company’s stock, valued at approximately $58,000.

Other large investors have also bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its holdings in Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock valued at $443,074,000 after acquiring an additional 3,239,203 shares during the last quarter. Nuveen LLC bought a new stake in shares of Xylem in the 1st quarter worth approximately $99,726,000. OVERSEA CHINESE BANKING Corp Ltd lifted its stake in Xylem by 390.5% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company’s stock valued at $122,009,000 after purchasing an additional 813,100 shares during the last quarter. Vaughan Nelson Investment Management L.P. bought a new stake in Xylem during the first quarter worth approximately $89,828,000. Finally, Swedbank AB grew its position in Xylem by 13.9% in the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after buying an additional 531,890 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Down 1.7%

NYSE:XYL opened at $144.30 on Monday. The business’s fifty day moving average price is $143.08 and its 200 day moving average price is $130.45. The firm has a market capitalization of $35.12 billion, a price-to-earnings ratio of 37.48, a PEG ratio of 2.49 and a beta of 1.13. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $151.16.

Xylem (NYSE:XYL) last released its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion for the quarter, compared to analysts’ expectations of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, sell-side analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio (DPR) is 41.56%.

Insider Activity at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

XYL has been the subject of a number of recent research reports. Zacks Research upgraded Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. Cowen reaffirmed a “hold” rating on shares of Xylem in a report on Tuesday, August 26th. UBS Group increased their price target on Xylem from $164.00 to $168.00 and gave the company a “buy” rating in a research report on Tuesday, August 5th. TD Cowen boosted their price objective on Xylem from $125.00 to $130.00 and gave the stock a “hold” rating in a report on Tuesday, August 26th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Xylem in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $154.67.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.